Target Price | $323.85 |
Price | $251.56 |
Potential |
28.74%
register free of charge
|
Number of Estimates | 8 |
8 Analysts have issued a price target Bio-Rad Laboratories Inc. - Ordinary Shares - Class A 2026 .
The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A target price is $323.85.
This is
28.74%
register free of charge
$411.60
63.62%
register free of charge
$247.45
1.63%
register free of charge
|
|
A rating was issued by 11 analysts: 7 Analysts recommend Bio-Rad Laboratories Inc. - Ordinary Shares - Class A to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bio-Rad Laboratories Inc. - Ordinary Shares - Class A stock has an average upside potential 2026 of
28.74%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.57 | 2.55 |
3.92% | 0.76% | |
EBITDA Margin | 11.78% | 16.41% |
15.42% | 39.27% | |
Net Margin | -71.85% | 9.50% |
201.30% | 113.22% |
9 Analysts have issued a sales forecast Bio-Rad Laboratories Inc. - Ordinary Shares - Class A 2025 . The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A sales estimate is
This results in the following potential growth metrics:
9 Bio-Rad Laboratories Inc. - Ordinary Shares - Class A Analysts have issued a net profit forecast 2025. The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -65.85 | 8.64 |
199.86% | 113.12% | |
P/E | 29.11 | |
EV/Sales | 2.51 |
9 Analysts have issued a Bio-Rad Laboratories Inc. - Ordinary Shares - Class A forecast for earnings per share. The average Bio-Rad Laboratories Inc. - Ordinary Shares - Class A EPS is
This results in the following potential growth metrics and future valuations:
Bio-Rad Laboratories Inc. - Ordinary Shares - Class A...
Analyst | Rating | Action | Date |
---|---|---|---|
Wells Fargo |
Locked
➜
Locked
|
Locked | Jun 09 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | May 02 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | May 02 2025 |
UBS |
Locked
➜
Locked
|
Locked | May 02 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Apr 17 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Feb 12 2025 |
RBC Capital |
Locked
➜
Locked
|
Locked | Jan 14 2025 |
Analyst Rating | Date |
---|---|
Locked
Wells Fargo:
Locked
➜
Locked
|
Jun 09 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
May 02 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
May 02 2025 |
Locked
UBS:
Locked
➜
Locked
|
May 02 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Apr 17 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Feb 12 2025 |
Locked
RBC Capital:
Locked
➜
Locked
|
Jan 14 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.